Evelyn Health

Evelyn Health sells direct-to-consumer prescription dermatology and hair-loss therapies that are compounded in partner pharmacies and shipped monthly. Core lines include topical and oral formulations of finasteride, minoxidil, tretinoin, clindamycin and spironolactone, priced at mid-range subscription tiers of US $30-60 per month. All consultations, billing and fulfillment are handled through the brand’s own telehealth platform; no physical retail is offered. The company differentiates by bundling asynchronous doctor consults, unlimited provider messaging and automatic refill synchronization into the subscription price. Every treatment plan is customized from 30-plus ingredient strengths, and progress photos are reviewed mid-cycle with free dosage tweaks. Its best-known bundle is the two-step “Hair Revival” set, advertised to show visible regrowth within 90 days under medical supervision. Primary customers are 20-45-year-old North American adults experiencing early-stage acne, hair thinning or anti-aging concerns who value discretion and time savings over in-office visits. The brand appeals to data-driven, app-native users who track biometrics, prefer transparent ingredient lists and want ongoing clinician access without insurance hurdles. Evelyn Health competes with telehealth platforms that repackage generic medications as well as with premium cosmetic brands selling non-prescription serums. It undercuts specialist co-pays by folding consultation fees into product price and outperforms OTC cosmetics by offering FDA-approved active pharmaceuticals in strength combinations unavailable off the shelf.